Please assess the completion status of the following clinical trial:

Trial Title: A Comparison of Olanzapine in Combination With a Mood Stabilizer vs Mood Stabilizer Alone, in Mixed Bipolar Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosed with a mixed episode of bipolar I disorder.~* Have had at least one previous manic or mixed episode associated with bipolar disorder~* You must be between 18 and 60 years old.~* You must be able to visit the doctor's office three times in the first week and then once every week for the next five weeks.~* If you are a female, you must have a negative pregnancy test and be using an effective method of contraception.~Exclusion Criteria:~* You have a diagnosis of schizophrenia, schizoaffective disorder or substance abuse or dependence.~* You have diseases of the intestinal tract, lungs, liver, kidney, nervous or endocrine systems, or blood.~* Have required a recent thyroid hormone supplement to treat hypothyroidism (must have been on a stable dose of the medication for at least 2 months prior to Visit 3).~* You are allergic to any of the medications involved in this study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): olanzapine and divalproex
- 2 (Type: PLACEBO_COMPARATOR): placebo and divalproex

Based on this trial design, predict the completion outcome and termination type (if applicable).